布地耐德混悬液联合博利康尼雾化吸入治疗急性发作期支气管哮喘  

Efficiency of budesonide suspension combining with terbutaline inhalation for acute onset of bronchial asthma

作　　者：伦茂春 

机构地区：[1]广西贵港市覃塘区人民医院呼吸内科,广西贵港537121

出　　处：《海南医学院学报》2011年第9期1179-1181,共3页Journal of Hainan Medical University

基　　金：海南医学院科研基金资助学报项目(0020110306)~~

摘　　要：目的:探讨布地奈德联合博利康尼雾化吸入治疗支气管哮喘急性发作期的疗效。方法:选取57例急性发作期支气管哮喘患者分为治疗组(30例)和对照组(27例)。两组均给与常规抗感染、祛痰以及氨茶碱平喘治疗,治疗组在常规治疗的基础上给予普米克令舒4 mL与博利康尼2 mL联合雾化吸入治疗,2次/日。结果:两组患者在治疗前观察指标差异无显著性(P>0.05),治疗后治疗组哮喘症状体征及肺功能指标明显改善(P<0.05)。结论:雾化吸入布地奈德和博利康尼起效快,有效改善患者的哮喘症状体征及肺功能指标。Objective： To observe the efficiency of budesonide suspension combining with terbutaline inhalation for acute onset of bronchial asthma.Methods： A total of 57 patients with acute stage of asthma were randomly divided into treatment group（30 cases） and control group（27 patients）.Both groups were given conventional anti-inflammatory,expectorant,and aminophylline treatment,while the treatment group was also given extra inhalation of bricanyl respules（4 mL） combinging with aerosol inhalation（2 mL）,twice per day.Results： There were no significant differences in observed paramaters before treatment（P 0.05）,while the treatment group showed significant better improvements in symptoms and signs than the control group（P0.05）.Conclusions： Inhalation of budesonide combing with bricanyl can improve lung function and relevant symptoms and signs in short time for patients with acute stage of bronchial asthma.

关 键 词：支气管哮喘 雾化吸入 布地耐德 博利康尼 

分 类 号：R725.6[医药卫生—儿科]